Acinetobacter baumannii complex, national laboratory-based surveillance in South Africa, 2017 to 2019.
Olga PerovicAdrian DuseVindana ChibabhaiMarianne BlackMohamed SaidElizabeth PrenticeJeannette WadulaYesholata MahabeerK Swe Swe HanRuth MogokotlengWilhelmina StrasheimMichelle LoweSabelle JallowHusna Ismailnull nullPublished in: PloS one (2022)
Our surveillance data contributed to a better understanding of the natural course of A. baumannii disease, the patient characteristics among infants, and the level of resistance. At least two-thirds of the isolates were extensively drug-resistant, and four percent of isolates were resistant to colistin.
Keyphrases
- acinetobacter baumannii
- drug resistant
- multidrug resistant
- south africa
- public health
- gram negative
- genetic diversity
- klebsiella pneumoniae
- pseudomonas aeruginosa
- case report
- electronic health record
- quality improvement
- hiv positive
- big data
- escherichia coli
- machine learning
- human immunodeficiency virus
- artificial intelligence